Navigation Links
Global Lyme Diagnostics Welcomes Dr. Mark Filidei and Dr. Jodie A. Dashore To Scientific Advisory Board
Date:8/3/2017

Global Lyme Diagnostics has announced that Dr. Mark Filidei, and Dr. Jodie Dashore have joined GLD's Scientific Advisory Board.

Dr. Filidei is an Internal Medicine physician and is the Director of Integrative/Functional Medicine for the Amen Clinics. Dr. Filidei is highly experienced in integrative/functional medicine modalities as well as conventional medicine and sees patients in person at the Amen Clinics Southern California. He was previously the medical director of the Whitaker Wellness Institute, the largest Integrative Medicine clinic in the United States where he spent over a decade treating thousands of patients for multiple complex medical issues. Dr. Filidei is an ILADS trained physician, which is the largest group of Lyme literate doctors in the world. He also has a special interest in diagnosing and treating CIRS (chronic inflammatory response syndrome) which is caused by toxic mold exposure. Dr Filidei lectures nationally on topics including the integrative approach to mental health, hormone replacement therapy, brain health, memory loss and Alzheimer’s disease, and mold and Lyme disease related issues.

Dr. Filidei correctly diagnosed Kris Kristofferson with Lyme Disease, after Kristofferson was misdiagnosed numerous times, with maladies ranging from Alzheimer's to fibromyalgia. The story was covered by news organizations such as CBS and was posted on the CMT website on July 8, 2016.

Dr. Jodie A. Dashore - Dr. Dashore has been a Lyme Literate Clinical practitioner since 2010. She specializes in an Integrative, alternative and plant-based medicine approach to Tick Borne Diseases and has been helping patients with Tick borne Infections from 11 countries around the globe. Dr. Dashore has given numerous national and international lectures on an integrative approach to Tick Borne infections. She is internationally recognized as a pioneering scientist and researcher who has coined the term "Complex Autism" (TM) to include Autism complicated with Tick Borne infections and other comorbid conditions.

Global Lyme Diagnostics has developed a breakthrough diagnostic solution specific to Lyme Disease that is grounded in science. The GLD test, developed by Dr. Marconi, is designed to significantly decrease the number of patients being misdiagnosed.

Dr. Marconi’s research has led to a novel breakthrough called chimeritopes which increase sensitivity by eliminating proteins that are not relevant to a Lyme infection (non-OsPC targets) and can further reduce false negatives by targeting Lyme causing bacteria variants across the North American spectrum. After licensing this technology platform and related intellectual property developed in Dr. Marconi’s lab at Virginia Commonwealth University, GLD focused on creating a highly accurate and reproducible solution.

"We are very pleased to have Dr. Filidei and Dr. Dashore join our Scientific Advisory Board. Their clinical advice will be extremely valuable in furthering GLD’s science to help the global Lyme community, " stated Mickey Ramchandani, CEO of Global Lyme Diagnostics. "Misdiagnosis is a core issue, as Lyme Disease can masquerade as many things - juvenile arthritis, fibromyalgia, chronic fatigue syndrome, multiple sclerosis and a host of other diseases. We are passionate about providing a diagnostic solution that decreases the misdiagnosis of Lyme Disease."

After years of research GLD has also just launched the GLD test, specific to Lyme Disease, which can be requested by clinicians at physician kit request. Patients that would like to request a kit to take to their clinicians can do so here. Note: The GLD Test is not yet available for CA, FL, or NY residents.

More information about GLD, including the science behind the new test and the Global Lyme Diagnostics team is available at the website at https://glymedx.com.

About Global Lyme Diagnostics:

GLD was formed with the sole purpose of providing a solution to the Lyme community including, physicians, clinicians, patients, advocates and families. Its initial focus is to develop and launch a test that is grounded in science and provides an answer to the challenges related to tests on the market. In addition to launching of their new test, GLD is working with the Lyme community and physicians to develop screening opportunities for worried individuals in Lyme endemic areas to help reduce long term complications. GLD is also researching methods to detect co-infections, as well as, assays that could differentiate early stage versus late stage infections for clinicians to better manage their patients.

Read the full story at http://www.prweb.com/releases/2017/08/prweb14567592.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Bactana Animal Health Announces Expansion of its Global Intellectual Property Portfolio
2. Ovation Fertility™ Supports Global Health Decision, AMA Designation of Infertility as a Disease
3. Global ISO Certification for Nova Oculus Device Paves the Way for Canadian Regulatory Approval
4. New Lyme Disease Test Now Available - Global Lyme Diagnostics, LLC
5. Leading Pharma and Research Organizations to Attend Genedata Screener Global User Group Meetings
6. Colpitts Clinical Continues to Provide Global Services to More Than 70 Countries
7. NetDimensions Global User Conference to Host Talent Leaders in EMEA and North America
8. NetDimensions Welcomes Bill Mastin as SVP, Global Sales
9. Membrane Microfiltration Market Expected to Reach $12,858 Million, Globally, by 2022-Allied Market Research
10. Navitas Life Sciences Augments Global Executive Management Team
11. Cert ID Wins BRC Global Standards CEO Award For 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... launched Rosalind™, the first-ever genomics analysis platform specifically designed for life science ... in honor of pioneering researcher Rosalind Franklin, who made a major contribution ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... will be hosting a Webinar titled, “Pathology is going digital. Is your lab ... digital pathology adoption best practices and how Proscia improves lab economics and realizes ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... DALLAS , Oct. 10, 2017 International research firm ... IoT Strategy, will speak at the TMA 2017 Annual Meeting , ... key trends in the residential home security market and how smart safety ... ... "The ...
Breaking Biology Technology:
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:4/24/2017)... April 24, 2017 Janice Kephart ... with  Identity Strategy Partners, LLP (IdSP) , today ... without President Trump,s March 6, 2017 Executive ... , refugee vetting can be instilled with greater confidence, ... now, all refugee applications are suspended by until ...
(Date:4/13/2017)... 13, 2017 UBM,s Advanced Design and Manufacturing ... feature emerging and evolving technology through its 3D Printing ... run alongside the expo portion of the event and ... demonstrations focused on trending topics within 3D printing and ... manufacturing event will take place June 13-15, 2017 at the ...
Breaking Biology News(10 mins):